NCT06907602 Optimizing Neoadjuvant Treatment Regimens for Locally Advanced Esophageal Squamous Cell Carcinoma Status RECRUITING Phase PHASE2/PHASE3
NCT06906887 PULSO Trial: Pulsed Low-Dose-Rate (PLDR) Radiation Chemoradiation (CRT) vs. Standard CRT for Esophageal Cancer Status RECRUITING Phase PHASE2
NCT06899126 Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer Status RECRUITING Phase PHASE3
NCT06896422 Randomized Trial of Glutathione With Anti-PD-1 and Chemotherapy in Advanced NSCLC Status RECRUITING Phase PHASE1
NCT06896188 9-ING-41 Combined With Retifanlimab, Plus Modified FOLFIRINOX for Patients With Advanced Pancreatic Adenocarcinoma (RiLEY) Status RECRUITING Phase PHASE1
NCT06866977 A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Advanced Pancreatic Cancer Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT06828614 Barriers to Therapeutic Exercise in Breast Cancer Patients Before, During, and After Chemotherapy Status ENROLLING_BY_INVITATION Phase N/A
NCT06803680 A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors Status RECRUITING Phase PHASE1
NCT06800339 A Study Evaluating Neoadjuvant Chemoimmunotherapy With Immunosensitizing Radiation for Borderline Resectable Non-Small Cell Lung Cancer Status RECRUITING Phase PHASE1
NCT06798246 HEFTME System for Adjuvant Therapeutic Selection of Locally Advanced UTUC Postoperatively:A Perspective Cohort Study Status NOT_YET_RECRUITING Phase N/A
NCT06794086 SBRT + PD-1 Monoclonal Antibody in Unresectable Colorectal Liver Metastases Status RECRUITING Phase PHASE3
NCT06788366 AI-HOPE Lung Cancer: Building a Predictive Tool for Metastatic Lung Cancer Status RECRUITING Phase N/A
NCT06776198 Precision Therapy Based on Immune Microenvironment by Transcriptome Sequencing of Osteosarcoma, a Prospective, Multi-cohort Exploratory Clinical Study Status NOT_YET_RECRUITING Phase N/A
NCT06767007 SBRT + PD-1 Antibody in Unresectable Locally Recurrent Rectal Cancer(SPARKLE) Status RECRUITING Phase PHASE2
NCT06758544 A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Resectable Pancreatic Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT06731478 Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer Status RECRUITING Phase PHASE3
NCT06728657 Preoperative HFRT Verses PULSAR for Locally Advanced GEJ or Proximal Gastric Adenocarcinoma Status SUSPENDED Phase PHASE2
NCT06727617 Serplulimab With Chemoradiotherapy for Postoperative Cervical Cancer With Risk Factors Status RECRUITING Phase PHASE2
NCT06727357 Next Generation Sequencing-based "Oncochip" for Therapeutic Decision in Metastatic Breast Cancer. Study SHARP Status ACTIVE_NOT_RECRUITING Phase PHASE2